Will Lantern Bioworks Lumina treatment be FDA Approved for preventing tooth decay by the end of 2026?

Low market probability for FDA approval of Lantern Bioworks Lumina treatment by 2026.

The prediction market indicates a 2.30% chance of FDA approval for the Lumina treatment, with a consensus leaning heavily towards a 'NO' outcome. The Pulse AI suggests a slightly higher probability of 5.8% for approval, but overall confidence remains moderate at 60/100, reflecting uncertainty in the approval process.

• 1 Current market sentiment strongly favors a NO outcome for FDA approval.
• 2 The market probability is significantly lower than the Pulse AI estimate.
• 3 A 3.5 edge indicates the market is fairly priced based on available data.
• 4 Time to expiry is substantial, allowing for potential developments in the approval process.
• 5 Confidence level of 60/100 suggests moderate uncertainty in the predictions.